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Abstract
Background: Severe dengue virus (DENV) disease is associated with extensive immune activation, characterized by a
cytokine storm. Previously, elevated lipopolysaccharide (LPS) levels in dengue were found to correlate with clinical disease
severity. In the present cross-sectional study we identified markers of microbial translocation and immune activation, which
are associated with severe manifestations of DENV infection.
Methods: Serum samples from DENV-infected patients were collected during the outbreak in 2010 in the State of Sa˜o Paulo,
Brazil. Levels of LPS, lipopolysaccharide binding protein (LBP), soluble CD14 (sCD14) and IgM and IgG endotoxin core
antibodies were determined by ELISA. Thirty cytokines were quantified using a multiplex luminex system. Patients were
classified according to the 2009 WHO classification and the occurrence of plasma leakage/shock and hemorrhage.
Moreover, a (non-supervised) cluster analysis based on the expression of the quantified cytokines was applied to identify
groups of patients with similar cytokine profiles. Markers of microbial translocation were linked to groups with similar
clinical disease severity and clusters with similar cytokine profiles.
Results: Cluster analysis indicated that LPS levels were significantly increased in patients with a profound pro-inflammatory
cytokine profile. LBP and sCD14 showed significantly increased levels in patients with severe disease in the clinical
classification and in patients with severe inflammation in the cluster analysis. With both the clinical classification and the
cluster analysis, levels of IL-6, IL-8, sIL-2R, MCP-1, RANTES, HGF, G-CSF and EGF were associated with severe disease.
Conclusions: The present study provides evidence that both microbial translocation and extensive immune activation occur
during severe DENV infection and may play an important role in the pathogenesis.
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Introduction
Dengue virus (DENV) infection has been emerging in the
American and Caribbean region in the past decade. During a
DENV-2 outbreak in 2010 in the State of Sa˜o Paulo, Brazil, more
than 34.000 cases and 64 deaths were reported by the Health
Department [1]. Symptoms of severe DENV infection range from
shock and respiratory distress to major hemorrhagic manifesta-
tions and organ failure. The majority of these symptoms are
manifest around the time of defervescence. In the early febrile
phase, DENV infection is characterized by a high viral load and
extensive activation of the Th1 response [2]. Around the time of
defervescence, virus titres often decrease below the limit of
detection. This critical phase is characterized by extensive immune
activation and a so-called cytokine storm (reviewed in [3]) that is
characterised by high levels of cytokines with mostly pro-
inflammatory properties. The mechanism underlying this cytokine
storm is still a matter of debate. Evidence points towards antibody-
dependent enhancement in which cross-reactive non-neutralizing
antibodies enhance the uptake of virus by monocytic cells
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(reviewed in [4]). Moreover, it has been proposed that ‘original
antigenic sin’ is important in the pathogenesis of dengue (reviewed
in [5]), postulating that low-avidity T cells are activated by the
virus, but fail to clear it.
During HIV infection, elevated levels of lipopolysaccharide
(LPS) were detected in the circulation and correlated with immune
activation [6]. There is evidence that a local pro-inflammatory
environment in the gut causes disruption of the intestinal barrier,
which may eventually result in microbial translocation (MT)
(reviewed in [7]). We recently showed that elevated LPS levels are
present during DENV infection and correlate with disease severity
[8]. DENV replicates in monocytes/macrophages, of which many
reside in the gut-associated lymphoid tissue (GALT). Therefore,
we hypothesized that this may cause a local pro-inflammatory
environment in the bowel, eventually affecting the integrity of the
intestinal barrier and resulting in MT. Consequently, because LPS
is known to be a potent immune stimulator, elevated LPS levels
may contribute to the cytokine storm during severe DENV
infection.
In the present study, we studied markers of MT and immune
activation in DENV infected patients. Using clinical classification
and a cluster analysis we have identified cytokines that correlate
with disease severity. Moreover, significantly increased LPS levels
were found in a cluster of patients with a pronounced pro-
inflammatory cytokine profile.
Materials and Methods
Ethics statement
All procedures adopted in this study were performed according
to the terms agreed by the Institutional Review Board from the
Hospital das Clı´nicas, University of Sa˜o Paulo (CAPPesq -
Research Projects Ethics Committee). This study was approved
by CAPPesq under protocol 0652/09. Written informed consent
was obtained from all study volunteers. All included study
participants were anonymized with a study number.
Clinical cohort
This cohort has been described previously [1]. Briefly, during
the 2010 outbreak samples were collected from patients with
clinical suspected dengue fever presenting at the emergency
department, department of internal medicine or the intensive care
unit at the Ana Costa Hospital, Santos, State of Sa˜o Paulo.
Patients were diagnosed with DENV infection by detection of
DENV NS1 antigen and/or IgM-specific antibodies using a
commercially available rapid test (Dengue duo test bioeasy,
Standard Diagnostic Inc. 575-34, Korea) or by detection of
DENV RNA by real time PCR (RT-PCR). Details concerning the
day of onset of fever (day of fever), clinical signs and symptoms and
the final diagnosis were recorded by the treating physician. Serum
samples were withdrawn and stored at 280uC. Patients were
classified according to the 2009 WHO classification [9,10] and the
occurrence of hemorrhagic manifestations and the occurrence of
plasma leakage and shock. Hemorrhagic manifestations were
observed by the treating physician. The occurrence of plasma
leakage was detected by ultrasound or X-ray examination. The
diagnosis shock was made by the treating physician based on
symptoms such as hypotension, narrow pulse pressure, tachycardia
and cold extremities. Age-matched healthy volunteers with a
similar socio-economic background were used as controls.
IgG avidity ELISA and viral load
The IgG avidity test was used to determine primary or
secondary DENV infection [11]. Samples with low avidity IgG
antibodies were classified as primary DENV infection, whereas
samples with high avidity IgG antibodies were classified as
secondary. Samples in which IgG antibodies were not detected
could not be classified, although the majority was probably
primary DENV infection.
Viral load was determined by an ‘‘in-house’’ RT-PCR method
and virus serotype was determined by a multiplex PCR. Both
methods have been described in detail previously [12]. For both
assays RNA was extracted from plasma using the Qiagen Viral
RNA kit (Qiagen, Germany). RT-PCRs were conducted in
duplicate. For the viral load SuperScript III Platinum SYBR
Green One-Step qRT-PCR kit with ROX (Invitrogen, Inc., EUA)
and for the dengue serotype multiplex PCR Platinum Taq
polymerase (Invitrogen, Brazil) was used. In both RT-PCRs
primers covering all four DENV serotypes were used [13].
Sequences of the primers were the following: D1, 59-TCA ATA
TGC TGA AAC GCG CGA GAA ACC G; TS1, 59- CGT CTC
AGT GAT CCG GGG G; TS2, 59- CGC CAC AAG GGC CAT
GAA CAG; TS3, 59-TAA CAT CAT CAT GAG ACA GAG C;
and DENV-4, 59-TGT TGT CTT AAA CAA GAG AGG TC.
Markers of MT
Samples were aliquoted and stored at 280uC. Repetitive freeze-
thaw cycles were avoided.
LPS was determined with a commercially available Limulus
Amebocyte Lysate (LAL) assay (Associates of Cape Cod Incorpo-
rated, USA). Samples were diluted 1:20 with LAL Reagent Water
and heat-inactivated at 60uC for 30 minutes. Depyrogenated
glassware was used to prevent contamination (Pyrotubes, Associ-
ates of Cape Cod Incorporated, USA). Hereafter, 50 ml of LAL
was added and samples were incubated in the Pyros Kinetix Flex
Machine (Associates of Cape Cod Incorporated, USA). Esche-
richia coli endotoxin was used to prepare the standard curve.
Soluble CD14 (sCD14; ‘Quantikine’ ELISA, R&D Systems, UK),
LPS binding protein (LBP ELISA, Hycult Biotech, USA) and IgM
and IgG endotoxin core antibodies (EndoCab ELISA, Hycult
Biotech, USA) were determined using commercially available
assays. The assays were performed according to the manufactur-
er’s instructions and every sample was measured in duplicate. One
patient was excluded from the LPS analysis due to extremely high
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the development of a cytokine storm. In a previous study
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identified cytokines that may contribute significantly to
the cytokine storm, and we could relate elevated levels of
LPS to patients with a pro-inflammatory cytokine profile.
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levels of LPS (56504 pg/ml) and therefore a secondary bacteremia
could not be excluded.
Cytokine measurements
Cytokines were measured using a multiplex immunoassay kit
with spectrally encoded antibody-conjugated beads (Human
Cytokine 30-plex panel, Invitrogen, USA). The following cytokines
were measured (Sensitivity limits (pg/ml): EGF (,18,8), Eotaxin
(,0), FGF-basic (,12,3), G-CSF (,38,5), GM-CSF (,40), HGF
(,0), IFN-a (,116), IFN-c (,34), IL-1RA (,116), IL-1b (,20),
IL-2 (,33), sIL-2R (,40), IL-4 (,108), IL-5 (,40), IL-6 (,13,5),
IL-7 (,60), IL-8 (,20), IL-10 (,47), IL-12 (p40/p70) (,40), IL-
13 (,60), IL-15 (,58), IL-17 (,80), IP-10 (,640), MCP-1 (,60),
MIG (,20), MIP-1a (,17), MIP-1b (,18), RANTES (,20),
TNF-a (,21) and VEGF (,823). Serum samples were diluted 1:2.
The test was performed according to the manufacturer’s instruc-
tions and was run on a Luminex 200 dual laser detection system.
Cluster analysis
The cluster analysis procedure was adapted from van den Ham
et al. [14]. Briefly, cytokine values were log-transformed and subjected
to hierarchical correlation clustering (i.e., with distance measure 1 –
pearson’s pairwise correlation value) using Ward’s method that
minimizes within-cluster variance. Both patients and cytokines were
clustered to obtain a heatmap. Cytokines that had more than 5% of
values missing (FGF-basic, GM-CSF, IL-1b, IL-5, IL-7, IL-13 and
Table 1. Baseline characteristics of the clinical classifications.
2009 WHO dengue case classification
WS2 (N=50) WS+ (N=49) Severe (N=33)
Sex 52% male 61,2% male 39,4% male
Age* 44 (28–57,5) 13,5 (9,25–30,25) 35,5 (15–58,5)
Day of fever* 3 (3–5) 5 (4–7) 6 (4–7)
Plasma leakage and shock
No (N=74) Plasma leakage (N=33) Shock (N=25)
Sex 52,7% male 66,7% male 32,0% male
Age* 38 (23–55,25) 13 (8–26) 42 (12–62,5)
Day of fever* 4 (3–6) 5 (3–8) 5,5 (4–7)
Hemorrhage
No (N=87) Minor bleeding (N=29) Severe bleeding (N=16)
Sex 54,0% male 51,7% male 43,8% male
Age* 38 (16–55) 22 (12–59) 31 (9–45)
Day of fever* 4 (3–6) 6 (4–9) 4 (3,5–7)
Baseline characteristics of the cohort when the patients are divided according to the 2009 WHO dengue case classification, the occurrence of plasma leakage and shock
and the occurrence of hemorrhagic manifestations. Abbreviations: WS2: non-severe dengue without warning signs, WS+: non-severe dengue with warning signs.
*values are given in median (interquartile range).
doi:10.1371/journal.pntd.0002236.t001
Figure 1. Viral load. A: Day of fever: All three groups differed significantly from each other with the highest levels at day 1–3 and the lowest levels
at day.7 (Day 1–3 vs day 4–7 P = 0,001; day 1–3 vs day.7 P,0,0001; day 4–7 vs day.7 P = 0,006). B: 2009 WHO dengue case classification: levels in
WS2 patients were significantly increased compared to WS+ and severe patients (WS2 vs WS+ P,0,0001; WS2 vs severe P = 0,001). Abbreviations:
WS2: non-severe dengue without warning signs, WS+: non-severe dengue with warning signs. Horizontal bars inside the boxplot indicate the
median. The box indicates the interquartile range. Black asterisk = significantly different from all other groups. The Mann-Whitney U test was used to
compare the groups with each other.
doi:10.1371/journal.pntd.0002236.g001
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Table 2. Overview of cytokine analyses.
Cytokine
Accession
number
2009 WHO
classification
Plasma leakage/
shock Hemorrhage Mortality
Temporal
pattern
Cluster
analysis Conclusion
Eotaxin P51671 -- -- -- -- -- -- No association
MIP-1a
(CCL3)
P10147 WS- vs HC P = 0,001
WS+ vs HC P = 0,004
No vs HC P = 0,001
PL vs HC P = 0,006
No vs HC P = 0,001 -- -- q cluster A* Background HC
TNF-a P01375 WS- vs HC P,0,0001
WS+ vs HC P,0,0001
Sev vs HC P = 0,002
No vs HC P,0,0001
PL vs HC P = 0,002
No vs HC P,0,0001
Minor vs HC P = 0,003
-- -- q cluster A* Background HC
IL-2 P60568 -- -- -- -- -- -- No association
IL-4 P05112 -- -- -- -- -- -- No association
IFN-c P01579 -- -- -- -- -- q cluster B* Early antiviral
response
IL-1RA P18510 -- -- -- -- -- q cluster C Association
severity in CA
IFN-a P01562 WS- vs HC P = 0,001
WS+ vs HC P = 0,003
Sev vs HC P = 0,001
No vs HC P = 0,001
PL vs HC P = 0,001
Shock vs HC
P = 0,003
No vs HC P = 0,001 Sev
vs HC P,0,0001
-- D1-3 vs D4-7
P = 0,002 D1-3 vs
D.7 P = 0,003
q cluster B* Early antiviral
response
IL-15 P40933 WS- vs HC P,0,0001
WS+ vs HC P,0,0001
Sev vs HC P,0,0001
No vs HC P,0,0001
PL vs HC P,0,0001
Shock vs HC
P,0,0001
No vs HC P,0,0001
Minor vs HC P,0,0001
Sev vs HC P,0,0001
No vs Sev P = 0,003
-- -- Q cluster A
q cluster C
Association
with dengue
in CC and severe
disease in CA
IP-10
(CXCL10)
P02778 WS- vs HC P,0,0001
WS+ vs HC P,0,0001
Sev vs HC P,0,0001
No vs HC P,0,0001
PL vs HC P,0,0001
Shock vs HC
P,0,0001
No vs HC P,0,0001
Minor vs HC P,0,0001
Sev vs HC P,0,0001
-- -- Q cluster A
q cluster C
Association with
dengue in CC and
severe disease in
CA
MIP-1b
(CCL4)
P13236 WS- vs HC P = 0,002
WS+ vs HC P,0,0001
Sev vs HC P = 0,002
No vs HC P = 0,001
PL vs HC P = 0,001
Shock vs HC
P = 0,004
No vs HC P,0,0001
Minor vs HC
P,0,0001
-- D1-3 vs D4-7
P,0,0001 D1-3 vs
D.7 P,0,0001
q cluster A* Association
dengue in CC. Early
antiviral response.
Background HC.
MIG
(CXCL9)
Q07325 WS- vs HC P,0,0001
Sev vs HC P = 0,002
No vs HC P,0,0001
Shock vs HC
P = 0,005
No vs HC P = 0,001
Sev vs HC P,0,0001
-- D1-3 vs D4-7
P = 0,008 D1-3 vs
D.7 P = 0,001
q cluster B*
q cluster C
Early antiviral
response.
Association severe
disease in CA
IL-10 P22301 Sev vs HC P = 0,008 -- -- -- -- q cluster C Association dengue
in CC and severe
disease in CA.
IL-12 P29459
P29460
WS+ vs HC P = 0,002 -- -- -- D1-3 vs D4-7
P = 0,001 D1-3 vs
D.7 P = 0,003
q cluster B* Early antiviral
response
G-CSF P09919 WS- vs Sev P = 0,003 No vs Shock
P = 0,002
No vs Sev P,0,0001 P = 0,001 -- q cluster C Association with
severe disease in
CC and CA
IL-6 P05231 WS- vs Sev P,0,0001
WS+ vs Sev P,0,0001
No vs Shock
P,0,0001 PL vs
Shock P = 0,001
No vs Sev P = 0,001 P,0,0001 -- q cluster C Highly associated
with severe disease
IL-8 P10145 WS+ vs Sev P = 0,004 -- No vs Sev P,0,0001
Minor vs Sev P = 0,002
-- D1-3 vs D4-7
P = 0,008
q cluster A*
q cluster C
Association with
severe disease in
CC and CA
RANTES
(CCL5)
P13501 WS- vs HC P = 0,001
WS+ vs HC P,0,0001
Sev vs HC P,0,0001
WS- vs Sev P = 0,002
No vs HC P,0,0001
PL vs HC P,0,0001
Shock vs HC
P,0,0001 No vs
Shock P,0,0001 PL
vs Shock P = 0,002
No vs HC P,0,0001
Minor vs HC
P,0,0001 Sev vs
HC P,0,0001
P = 0,005 -- Q cluster C Highly associated
with severe disease
EGF P01133 WS- vs HC P,0,0001
WS+ vs HC P,0,0001
Sev vs HC P,0,0001
No vs HC P,0,0001
PL vs HC P,0,0001
Shock vs HC
P,0,0001 No vs
Shock P = 0,004
No vs HC P,0,0001
Minor vs HC P,0,0001
Sev vs HC P,0,0001
-- -- q cluster A
Q cluster C
Increased levels
background HC.
Decreased levels
associated with
severe disease in
CC and CA
HGF P14210 WS- vs WS+ P = 0,005
WS- vs Sev P = 0,001
No vs Shock
P = 0,001
-- -- q cluster C Associated with
severe disease in
CC and CA
Immune Activation, LPS and Severe Dengue
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IL-17) were excluded from the analyses. Three serum samples were
excluded from the cytokine analysis, because their levels were out of
range for most of the cytokines evaluated and therefore the quality of
the sample was most likely compromised. Cluster analysis was
performed in R 2.15 (R Development Core Team [R Foundation for
Statistical Computing], 2012, www.r-project.org). R scripts used to
construct the trees and heatmaps are available upon request.
Statistical analysis
The Kruskal-Wallis H test was used for comparison of more
than two groups. Statistical significance between individual groups
was determined with the Mann-Whitney U test. Using the
Bonferroni correction a p-value cut-off of #0.0083 for cytokine
analyses was applied. For testing the significance of LPS, LBP and
sCD14 levels associated with the clinical classifications and the
clusters a p-value cut-off #0.05 was used. Correlations were
calculated using the Spearman’s correlation coefficient. To
calculate the association of severe disease with the three main
clusters the Fisher’s exact test was used. For this test we used a p-
value cut-off #0,05 to reach significance.
Results
Cohort
During the 2010 outbreak serum samples were obtained from
811 patients with laboratory confirmed acute DENV infection.
From this cohort, 99 patients with non-severe dengue were
randomly selected based on the availability of samples and clinical
data. Moreover, patients with severe co-morbidity were excluded.
Eventually, 50 patients without warning signs (WS2) and 49 with
warning signs (WS+) were selected. Only 33 patients presented
with severe dengue according to the 2009 WHO case classification
[10] and they were all included in this analysis. Among patients
with warning signs, 29/49 (59.2%) showed plasma leakage
diagnosed by ultrasound/X-rays (pleural and peritoneal 12;
peritoneal 12; pleural 5), 23 (46.9%) showed mucosal bleeding,
14 (28.6%) persistent vomiting, 5 (10,2%) abdominal pain and 3
(6,1%) lethargy. Among patients with severe dengue, 27/33
(81,8%) showed signs of severe plasma leakage (25 shock, 2 fluid
accumulation leading to respiratory distress), 14 (42,4%) showed
severe bleeding and one (3,0%) severe liver involvement (AST and
ALT.1000). The clinical presentation and general characteristics
of the cohort are described in Table 1.
Of the 132 patients included, three had a primary and 113 had
a secondary infection based on the IgG avidity test [11]. In 16
patients IgG antibodies could not be detected.
Viral load and dengue serotype
Viral RNA was detected in 120 of 132 samples. Significantly
higher DENV RNA load was detected in samples collected 1–3
days after onset of fever compared to day 4–7 and day .7
(Figure 1). Moreover, DENV RNA levels were significantly higher
in WS- patients compared to WS+ and severe patients, but this
difference occurred most likely because they presented earlier after
the onset of fever (Figure 1, Table 1).
Dengue serotype could be determined in 126/811 (15.5%)
patients with laboratory confirmed acute DENV infection during
the 2010 Santos outbreak. From these, 118/126 (93.7%) typed as
DENV-2, 4 (3.2%) as DENV-1 and 4 (3.2%) as DENV-3. Among
the 132 patients included in this study, DENV serotype could be
determined in 20 (15.2%) patients. 19 out of 20 patients were
typed as DENV-2 and the remaining one as DENV-3.
Association of levels of circulating cytokines with clinical
disease severity
Eotaxin, IL-2, IL-4, IL-1RA and IFN-c were detected at very
low levels in DENV infected patients and healthy controls and
did not show any significant differences between groups when
patients were classified according to the 2009 WHO classification
or the occurrence of plasma leakage/shock and hemorrhage
(Table 2). In the majority of samples MIP-1a and TNF-a also
showed values below the detection limit. However, some healthy
controls showed extremely elevated levels and therefore a
significant difference between healthy controls and dengue
patients was shown (Table 2).
IFN-a, IL-10, IL-12 IL-15, IP-10, MIG and MIP-1b were
significantly increased or decreased in dengue patients compared
to healthy controls if patients were classified according to the
2009 WHO classification (Table 2, Figure S1). These cytokines
did not show significant differences among the disease severity
groups.
Some cytokines showed significant differences in levels between
dengue disease severity groups. Using the 2009 WHO dengue case
classification, levels of RANTES and MCP-1 were significantly
increased in WS2 patients compared to patients with severe and
Table 2. Cont.
Cytokine
Accession
number
2009 WHO
classification
Plasma leakage/
shock Hemorrhage Mortality
Temporal
pattern
Cluster
analysis Conclusion
MCP-1
(CCL2)
P13500 WS+ vs HC P = 0,008
WS- vs WS+ P = 0,001
-- -- -- D1-3 vs D4-7
P,0,0001 D1-3 vs
D.7 P,0,0001
q cluster B*
q cluster C
Early antiviral response.
Association severe
disease in CC and CA
VEGF P15692 -- -- -- -- -- q cluster C Association with severe
disease in CA
IL-2R A2N4P8 -- -- Sev vs HC P = 0,003
No vs Sev P = 0,002
Minor vs Sev
P = 0,008
P = 0,005 -- q cluster C Highly associated
with severe disease,
hemorrhage in
particular.
Overview of the significant associations of all analyses performed and specified per cytokine. The Mann-Whitney U test was used to compare the groups with each
other. Abbreviations: HC: healthy control. 2009 WHO classification: WS-: non-severe dengue without warning signs, WS+: non-severe dengue with warning signs, Sev:
severe dengue. Plasma leakage/shock: No : no plasma leakage occured, PL: plasma leakage detected, Hemorrhage: No : no hemorrhagic symptoms, Minor: minor
hemorrhage, Sev: severe hemorrhage. Temporal pattern: D1-3: day 1-3 after the onset of fever, D4-7: day 4-7 after the onset of fever, D.7: more than 7 days after the
onset of fever. Cluster analysis: * only in a part of the cluster this cytokine is up- or downregulated. Conclusions: CC: clinical classification, CA: cluster analysis.
doi:10.1371/journal.pntd.0002236.t002
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WS+ dengue respectively. In contrast, levels of IL-6, IL-8, HGF
and G-CSF were significantly increased in severe dengue
compared to uncomplicated disease (Table 2, Figure 2).
When these cytokines were determined in patients classified
according to the occurrence of plasma leakage and shock, levels of
RANTES and EGF were significantly decreased in patients with
shock compared to patients with uncomplicated dengue. More-
over, levels of IL-6, HGF and G-CSF were significantly increased
in shock patients compared to patients with uncomplicated disease
(Table 2, Figure 3).
Patients were also classified according to the occurrence of
hemorrhage. Levels of sIL-2R, IL-6, IL-8, IL-15 and G-CSF were
significantly increased in patients with severe bleeding compared
to patients with no bleeding (Table 2, Figure S2).
Nine out of 132 patients died within 14 days after the onset of
fever. In these patients IL-6, G-CSF and sIL-2R were significantly
increased and RANTES significantly decreased in non-survivors
compared to survivors (Table 2, Figure 4).
IFN-a, IL-12, MCP-1, MIG, MIP-1b showed a dynamic
temporal pattern during the course of disease. They were
significantly increased at day 1–3 after the onset of fever compared
to day 4–7 and day.7 (Table 2, Figure S3). This may explain why
the levels of MCP-1 were significantly higher in uncomplicated
than in more severe dengue in patients classified according to the
2009 WHO dengue case classification, since patients with non-
severe dengue presented earlier in their course of disease (Table 1).
Interestingly, the mediators IFN-a (P = 0.001), IL-12 (P = 0.01),
MCP-1 P,0.0001), MIG (P = 0,01) and MIP-1b (P,0.0001)
showed to have a significant positive correlation with the viral load
(data not shown).
Cluster analysis identifies a group of patients with a pro-
inflammatory cytokine profile
The cluster analysis groups samples or cytokines based on
cytokine levels only, and not based on clinical presentation (non-
supervised analysis). The sample and cytokine cluster analyses can
be combined and visualized as a heatmap (Figure 5). A
dendrogram shows the similarity between samples (left side of
figure 5), where samples in the same branch are more similar
regarding their cytokine profiles to each other than to samples in
Figure 2. Cytokine levels in dengue virus infected patients classified according to the 2009 WHO dengue classification. A: IL-6: Levels
in severe patients are significantly increased compared WS2 (P,0,0001) and WS+ (P,0,0001) patients (KW P,0,0001, KW dengue groups P,0,0001).
B: IL-8: Levels in severe patients are significantly elevated compared to WS+ patients (P = 0,004) (KW P = 0,004, KW dengue groups P = 0,011). C:
RANTES: Levels in severe (P = 0,002) patients are significantly decreased compared to WS2 patients. Levels in all patient groups are significantly
decreased compared to HC (WS2 vs HC P = 0,001, WS+ and severe vs HC P,0,0001), (KW P,0,0001, KW dengue groups P = 0,006). D: MCP-1: Levels in
WS+ patients are significantly decreased compared to WS2 (P = 0,001) patients and HC (P = 0,008) (KW P = 0,006, KW dengue groups P = 0,006). E:
HGF: Levels in severe (P = 0,001) and WS+ (P = 0,005) patients are significantly increased compared to WS-patients (KW P = 0,001, KW dengue groups
P = 0,001). F: EGF: Levels in all patient groups are significantly decreased compared to HC (WS2, WS+ and severe vs HC P,0,0001, KW P,0,0001, KW
dengue groups P = 0,03). G: G-CSF: Levels in severe patients are significantly increased compared to WS- patients (P = 0,003, KW P = 0,02, KW dengue
groups P = 0,008). Legend: HC = healthy control, WS2= non-severe dengue without warning signs. WS+= non-severe dengue with warning signs,
KW = kruskal wallis. Horizontal bars inside the boxplot indicate the median. The box indicates the interquartile range. Black asterisk = significantly
different from all other groups. Underlined black asterisk = significant difference between two groups. The Mann-Whitney U test was used to
compare the groups with each other.
doi:10.1371/journal.pntd.0002236.g002
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other branches. The sample dendrogram can be divided into three
principle clusters that largely segregate healthy controls (cluster A),
mild to moderately ill DENV infected patients (cluster B), and
severely ill DENV infected patients (cluster C). Clinical disease was
more severe in cluster C than in clusters A and B, illustrated by a
statistically significant higher incidence of severe disease
(P = 2,2610216), shock (3,461025), severe hemorrhage
(P = 0,007) and death (P = 0,03) in this cluster compared to cluster
A and B (Table 3).
A subgroup of ‘healthy control’ cluster A displayed elevated
levels of inflammatory cytokines when compared to other control
samples, including MIP-1a, MIP-1b, TNF-a, EGF and IL-8.
These controls are likely to have suffered from an underlying
unidentified inflammatory condition (Table 2, Figure 5).
The majority of dengue cases were part of cluster B. In cluster B
40% of patients suffered from WS2, 39% from WS+ and 21%
from severe dengue (Table 3). This distribution resembles the
whole cohort, which consisted of 38% WS2, 37% WS+ and 25%
severe dengue. The cytokine pattern in this cluster shows a rather
diffuse pattern. A few patients show increased concomitant
expression of IFN-c, IFN-a, MCP-1, MIG and IL-12, which is
indicative for an early antiviral response.
Cluster C shows a strong pro-inflammatory cytokine pattern.
RANTES and EGF are downregulated, whereas IL-6, IL-8, IL-10,
IL-15, IL-1RA, sIL-2R, HGF, VEGF, G-CSF, MCP-1, IP-10, and
MIG are upregulated compared to other clusters. Interestingly, IL-
1RA, IL-10, IL-15, IP-10, MIG and VEGF are associated with
severe disease in the cluster analysis, but not with severe disease
using the clinical classifications. Using for example the 2009 WHO
classification IL-10, IL-15, IP-10 and MIG were significantly
elevated in dengue patients compared to healthy controls, but
levels were not significantly elevated in severe compared to
uncomplicated dengue. Cluster C identifies a group of patients
with an extensive pro-inflammatory cytokine profile, suggestive for
a cytokine storm. Moreover, severe clinical symptoms occurred
significantly more often in cluster C compared to the other clusters.
MT is associated with severe dengue
Statistically significant elevated LPS levels were found in cluster
C compared to ‘dengue’ cluster B and ‘healthy control’ cluster A
Figure 3. Cytokine levels in dengue virus infected patients classified according to the occurrence of plasma leakage/shock. A: IL-6: Levels
in shock patients are significantly increased compared to patients with (P = 0,001) and without (P,0,0001) plasma leakage (KW P,0,0001, KW dengue
groups P,0,0001). B: IL-8: No significant differences (KW P = 0,01, KW dengue groups P = 0,04). C: RANTES: Levels in shock patients are significantly
decreased compared to patients with (P = 0,002) and without (P,0,0001) plasma leakage. Levels in all patient groups are significantly decreased compared
to HC (No, PL and shock vs HC P,0,0001, KW P,0,0001, KW dengue groups P = 0,001). D: MCP-1: No significant differences (KW P = 0,162, KW dengue
groups P = 0,17). E: HGF: Levels in patients with shock are significantly increased compared to patients with no plasma leakage (P = 0,001) (KW P = 0,001,
KW dengue groups P = 0,001). F: EGF: Levels in shock patients are significantly decreased compared to patients without (P = 0,004) plasma leakage. Levels
in all patient groups are significantly decreased compared to HC (No, PL and shock vs HC P,0,0001, KW P,0,0001, KW dengue groups P = 0,015). G: G-CSF:
Levels in patients with shock are significantly elevated compared to patients without plasma leakage (P = 0,002, KW P = 0,01, KW dengue groups P = 0,004).
Abbreviations: HC = healthy control, No = no occurrence of plasma leakage, PL = plasma leakage, KW = kruskal wallis. Horizontal bars inside the boxplot
indicate the median. The box indicates the interquartile range. Black asterisk = significantly different from all other groups. Underlined black
asterisk = significant difference between two groups. The Mann-Whitney U test was used to compare the groups with each other.
doi:10.1371/journal.pntd.0002236.g003
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(Figure 6). In the 2009 classification there proved to be a trend
towards higher LPS levels in severe dengue, although these
differences were not statistically significant. However, in the
plasma leakage/shock classification LPS levels were significantly
increased in patients with shock compared to patients with no
plasma leakage. In the 2009 classification, LBP levels were
significantly increased in dengue patients compared to healthy
controls. Moreover, levels in severe patients were significantly
increased compared to WS2 patients. In the plasma leakage/
shock classification levels were significantly increased in patients
with shock and no plasma leakage compared to healthy controls.
Moreover, levels in patients with shock were significantly increased
compared to patients with plasma leakage. In the cluster analysis
LBP levels in all three clusters differed significantly from each
other. sCD14 levels were significantly increased in DENV infected
patients compared to healthy controls in the 2009 and the plasma
leakage/shock classification and in the ‘dengue’ clusters B and C
compared to the ‘healthy control’ cluster A. Moreover, in the 2009
classification levels in WS+ patients were significantly increased
compared to WS2 patients. When patients were classified
according to the occurrence of hemorrhagic manifestations, LPS
levels were not significantly different, and sCD14 and LBP again
showed to be significantly elevated in DENV infected patients
compared to controls (Data not shown). No significant differences
in IgM- and IgG-specific endotoxin core antibodies were found
among the groups classified according to the 2009 classification or
the occurrence of plasma leakage and shock (Data not shown).
Discussion
In this study, we have examined a cohort of dengue patients and
healthy controls to investigate the role of immune activation and
MT in DENV pathogenesis. We found evidence for the
occurrence of MT during DENV infection. Furthermore, in the
cluster analysis, we showed that the cluster of patients with the
highest LPS levels appeared to suffer from a cytokine storm.
The two complementary analysis techniques applied in this
study yielded similar results. However, the cluster analysis
identified more markers associated with severe disease than the
clinical classification system. The cluster analysis groups patients
based on the occurrence of identical inflammatory processes,
overcoming the potential clinical classification biases that may
occur due to the fact that disease presentation of patients can be
quite variable and the severity of disease is subject to clinical
interpretation. In the cluster analysis, levels of cytokines deter-
mined the outcome of the clusters. Therefore this technique
cannot be used to relate absolute values of cytokines to the clusters
with patients. Altogether, the strength of our approach is the use of
both clinical classification and cluster analysis in order to increase
the sensitivity to find markers of disease severity.
One limitation of this study is the cross-sectional study design.
We have recorded the disease severity of the patient at the time of
inclusion and at the same moment the samples for LPS and cytokine
analysis were drawn, so the levels of LPS and cytokines were related
to signs and symptoms that were present at that same time.
Figure 4. IL-6, IL-8, IL-2R and RANTES are associated with mortality. A: IL-6: Levels are significantly elevated in non-survivors compared to
survivors (P,,0,0001). B: IL-2R: Levels are significantly elevated in non-survivors compared to survivors (P = 0,005). C: G-CSF: Levels are significantly
elevated in non-survivors compared to survivors (P = 0,001). D: RANTES: Levels are significantly decreased in non-survivors compared to survivors
(P = 0,005). Underlined black asterisk = significant difference between two groups. The Mann-Whitney U test was used to compare the groups with
each other.
doi:10.1371/journal.pntd.0002236.g004
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Both in a previous [8] and in the present study, we have shown
that elevated levels of LPS are associated with severe dengue.
Moreover, MT was indirectly confirmed by increased levels of
LBP and sCD14 as observed in sepsis patients [15,16]. In contrast
to our previous study, the association between LPS levels and
clinical disease severity was less strong. However, also in this study
there proved to be a significant association in patients classified
according to the occurrence of plasma leakage and shock.
Moreover, LPS levels were significantly increased in the cluster
with the highest incidence of shock (cluster C) and levels of LBP
did also show a direct association with disease severity in the 2009
and the plasma leakage/shock classification. This cohort differed
from our previous study in several ways: age of the population
(children vs. children and adults), the geographical location
(Indonesia vs. Brazil) and the samples used (plasma vs. serum).
Whether age or different pathogen pressures at different
Figure 5. Heatmap of cluster analysis. A cluster analysis was performed with 23 cytokines, which resulted in a dendrogram indicated on the left
of the heatmap. Every horizontal line indicates one patients. The vertical bar on the left of the heatmap indicates the disease severity of the patient. A:
Cluster with mainly healthy controls and four dengue patients. B: Cluster with mild to moderately ill dengue virus infected patients. C: Cluster with
severely ill dengue virus infected patients. Abbreviations: 1: non-severe dengue without warning signs. 2: non-severe dengue with warning signs. 3:
severe dengue. +: patient died within 14 days after the onset of fever.
doi:10.1371/journal.pntd.0002236.g005
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geographical locations may account for the observed differences
remain to be established. IgM and IgG endotoxin core antibodies
were determined, but no strong association with disease severity
was found. This is in agreement with studies in HIV and sepsis
patients, which show conflicting results with regards to the
association between endotoxin core antibodies and disease severity
[6,17,18].
It has been hypothesized that severe DENV infection is caused
by an exaggerated immune response, associated with a cytokine
storm (reviewed in [3,19]). The exact definition of a cytokine storm
is still a matter of debate. In general it is assumed that a cytokine
storm starts with an excessive release of pro-inflammatory
cytokines (e.g. TNF-a and IL-1b). These cytokines then induce
other pro-inflammatory (e.g. IL-6), but also anti-inflammatory
cytokines (e.g. IL-10). This augmented immune response could
therefore be the result of a disturbed balance between pro- and
anti-inflammatory cytokines. During severe DENV infections a
cytokine storm has been proposed to be responsible for the
increased vascular permeability and coagulation disturbances
(reviewed in [19]).
Studies in patients with HIV and visceral leishmaniasis showed
that MT may contribute to severe disease through excessive
immune activation [6,20]. It is known that LPS stimulation can
induce the production of IL-6, IL-8, TNF-a and IL-1b [21] and
the growth factors VEGF and HGF [22]. Interestingly, in the
present study high levels of four of these markers were found in the
pro-inflammatory cluster C. This suggests that MT may play a
role in the cytokine storm in severe dengue. Moreover, Bosisio
et al. [23] showed that priming of mononuclear cells with IFN-c
increased the expression of the TLR4 receptor and subsequent
LPS-induced cytokine production. This would suggest that DENV
induced IFN-c production could enhance the pro-inflammatory
LPS signaling pathway. In addition, Chen et al. [24,25] showed
that LPS could prolong DENV infection of monocytes and
macrophages. A sustained DENV infection due to MT may also
contribute to the cytokine storm during DENV infection. All these
studies suggest that MT may play an important role in the
initiation and perpetuation of the cytokine storm during severe
DENV infection. However, in this study MT was associated with
extensive immune activation, but to investigate whether there is a
causal relationship between MT and the cytokine storm further
studies are warranted.
Our cohort confirms several known associations for dengue. In
agreement with previous work, our study showed evidence of a
strong Th1 response in the early phase of disease with peak levels
of IFN-a [26,27], IL-12 [28,29,30], MCP-1 [31,32,33], MIG and
MIP-1b [31]. All these Th1 cytokines correlated significantly with
viral load, suggesting that they are associated with a host response
aiming at reducing the viral load.
In the present study we have quantified pro- and anti-
inflammatory mediators to provide evidence for a role of a
cytokine storm in severe dengue patients. Levels of IL-10, IL-15,
VEGF, G-CSF and IP-10 were increased in ‘severe dengue’ cluster
C in the cluster analysis. High levels of IL-10 and VEGF have
been described in severe dengue, especially at the day of
defervescence [2,28,29,34,35]. Interestingly, patients in severe
cluster C presented around this time (day 3–5 after onset of fever).
The high incidence of shock in cluster C could be partly explained
by high levels of VEGF and MCP-1, which are proposed to be
important contributors to plasma leakage [33,35]. IL-15 and IP-10
[36] were reported to play an important role in the NK cell
response, whereas G-CSF [37] stimulates neutrophil development
and differentiation. High levels of IL-15, IP-10 and G-CSF in
cluster C suggest that extensive activation of the innate immune
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system may contribute to the cytokine storm in severe dengue. In
contrast, high levels of IL-10 have an inhibitory effect on dendritic
cells and macrophages (reviewed in [38]).
In both the clinical classifications and the cluster analysis, IL-6,
IL-8, sIL-2R, RANTES, HGF and EGF were strongly associated
with severe disease. High levels of IL-6 and IL-8 were reported in
dengue cases with severe plasma leakage and shock [39] and in
non-survivors [40,41,42]. IL-6 production is induced by TNF-a
and IL-1b [37]. In our study no increased levels of TNF-a and IL-
1b were found. This is in agreement with earlier reports
[31,34,39,42,43] and can be explained by the observation that
TNF-a and IL-1b are produced early after infection and are
removed quickly from the circulation. In addition, sIL-2R has
been associated with severe dengue [2,27,43] and is proposed to
serve as a marker of immune activation (reviewed in [44]).
Thrombocytopenia is a hallmark of DENV infection and since
thrombocytes are an important source of RANTES and EGF,
severe thrombocytopenia may explain the depletion of these two
markers. This has been described previously in severe dengue [28]
and cerebral malaria [45].
In summary, we provide evidence that MT is associated with
extensive immune activation during severe dengue. LPS may play
an important role in the development of the cytokine storm.
Besides the classical mediators (e.g. IL-6, IL-8, IL-10), we
identified cytokines (IL-1RA, sIL-2R), chemokines (MCP-1, IP-
10, MIG, RANTES) and growth factors (HGF, EGF, G-CSF,
VEGF) that may play an important role in the cytokine storm
during severe DENV infection.
Figure 6. LPS, LBP and sCD14 levels in dengue virus infected patients. LPS: A: No significant differences in the 2009 WHO dengue case
classification. B: Levels in patients with shock were significantly increased compared to patients without plasma leakage (P = 0,04). C: Cluster analysis:
cluster C was significantly elevated compared to cluster A (P = 0,01), and B (P = 0,02). LBP: D: Levels were significantly elevated in all dengue patients
compared to HC (WS2 vs HC P = 0,009, WS+ vs HC P = 0,03, Severe vs HC P = 0,01). Levels in patients with severe dengue were significantly elevated
compared to WS2 dengue (P = 0,03). E: Levels were elevated in patients with shock (P = 0,008) and no plasma leakage (P = 0,008) compared to HC.
Levels were also elevated in patients with shock compared to patients with plasma leakage (P = 0,03). F: In the cluster analysis levels in cluster C were
significantly elevated compared to cluster A (P = 0,002) and B (P = 0,007). Moreover, cluster B was significantly elevated compared to cluster A
(P,0,0001). sCD14: G: In the 2009 classification levels of sCD14 in DENV infected patients were significantly elevated compared to HC (WS2, WS+ and
severe vs HC P,0,0001). Levels were significantly increased in WS+ compared to WS2 patients (P = 0,04). H: In the plasma leakage/shock classification
levels of sCD14 in DENV infected patients were significantly elevated compared to HC (No, PL and shock vs HC P,0,0001). I: In the cluster analysis
cluster B (P,0,0001) and C (P = 0,002) were significantly elevated compared to cluster A. Abbreviations: HC : healthy control, WS2: non-severe
dengue without warning signs. WS+: non-severe dengue with warning signs, No : No occurrence of plasma leakage, PL: occurrence of plasma
leakage. Horizontal bars inside the boxplot indicate the median. The box indicates the interquartile range. Black asterisk = significantly different from
all other groups. Underlined black asterisk = significant difference between two groups. The Mann-Whitney U test was used to compare the groups
with each other.
doi:10.1371/journal.pntd.0002236.g006
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Figure S1 Cytokine levels in dengue virus infected
patients are significantly different compared to healthy
controls. A: IFN-a: Levels in DENV infected patients are
significantly elevated compared to HC (WS2 vs HC P = 0,001,
WS+ vs HC P = 0,003 and severe vs HC P = 0,001, KW P = 0,005,
KW dengue groups P = 0,93). B: IL-15: Levels in DENV infected
patients are significantly elevated compared to HC (WS2, WS+
and severe vs HC P,0,0001, KW P,0,0001, KW dengue groups
P = 0,08). C: IP-10: Levels in DENV infected patients are
significantly elevated compared to HC (WS2, WS+ and severe vs
HC P,0,0001, KW P,0,0001, KW dengue groups P = 0,82). D:
MIP-1b: Levels in dengue patients are significantly decreased
compared to HC (WS2 vs HC P = 0,002, WS+ vs HC P,0,0001,
Sev vs HC P = 0,002, KW P = 0,002, KW dengue groups
P = 0,31). E: MIG: Levels in WS2 (P,0,0001) and severe
(P = 0,002) patients are significantly elevated compared to HC
(KW P,0,0001, KW dengue groups P = 0,03). F: IL-10: Levels in
severe patients are significantly elevated compared to HC
(P = 0,008, KW P = 0,08, KW dengue groups P = 0,54). G: IL-
12: Levels in WS+ patients are significantly decreased compared
to HC (P = 0,002, KW P = 0,05, KW dengue groups P = 0,26).
Abbreviations: HC = healthy control, WS2= non-severe dengue
without warning signs. WS+= non-severe dengue with warning
signs. Horizontal bars inside the boxplot indicate the median. The
box indicates the interquartile range. Black asterisk = significantly
different from all other groups. Underlined black asterisk = signi-
ficant difference between two groups. The Mann-Whitney U test
was used to compare the groups with each other.
(EPS)
Figure S2 Cytokine levels in dengue virus infected
patients classified according to the occurrence of
hemorrhage. A: IL-6: Levels are significantly elevated in
patients with severe bleeding compared to patients with no
hemorrhage (P = 0,001) (KW P = 0,007, KW dengue groups
P = 0,003). B: IL-8: Levels in patients with severe bleeding are
significantly elevated compared to patients with minor (P = 0,002)
and no (P,0,0001) hemorrhage (KW P = 0,001, KW dengue
groups P = 0,001). C: IL-15: Levels in patients with severe
hemorrhage are significantly elevated compared to patients with
no hemorrhage (P = 0,003). Levels in HC are significantly
decreased compared to all other dengue groups (WS2, WS+
and severe vs HC P,0,0001) (KW P,0,0001, KW dengue groups
P = 0,009). D: sIL-2R: Levels are significantly elevated in patients
with severe bleeding compared to HC (P = 0,003) or patients with
minor (P = 0,008) or no hemorrhage (P = 0,002) (KW P = 0,013,
KW dengue groups P = 0,007). E: G-CSF: Levels in patients with
severe hemorrhage are significantly increased compared to
patients with no hemorrhage (P,0,0001) (KW P = 0,005, KW
dengue groups P = 0,002). Abbreviations: HC = healthy control,
No = No occurrence of hemorrhage. KW = kruskal wallis. Hori-
zontal bars inside the boxplot indicate the median. The box
indicates the interquartile range. Black asterisk = significantly
different from all other groups. Underlined black asterisk = signi-
ficant difference between two groups. The Mann-Whitney U test
was used to compare the groups with each other.
(EPS)
Figure S3 Levels of cytokines during the course of
disease. A: IFN-a: Levels at day 1–3 were significantly increased
compared to day 4–7 (P = 0,002) and day.7 (P = 0,003) (KW
P = 0,001). B: MCP-1: Levels at day 1–3 were significantly
increased compared to day 4–7 (P,0,0001) and day.7
(P,0,0001) (KW P,0,0001). C: MIG: Levels at day 1–3 were
significantly increased compared to day 4–7 (P = 0,008) and
day.7 (P = 0,001) (KW P = 0,001). D: MIP-1b: Levels at day 1–3
were significantly increased compared to day 4–7 (P,0,0001) and
day .7 (P,0,0001) (KW P,0,0001). E: IL-12: Levels at day 1–3
were significantly increased compared to day 4–7 (P = 0,001) and
day .7 (P = 0,003) (KW P = 0,001). Abbreviations: KW = kruskal
wallis. Black asterisk = significantly different from all other groups.
The Mann-Whitney U test was used to compare the groups with
each other.
(EPS)
Acknowledgments
We would like to thank Dr. Jose´ Luiz Boechat Paione, Dra. Olimpia
Nakasone, Mariangela Libo´rio and all other employees from the hospital
Ana Costa for their participation in the recruitment of patients and clinical
data and sample collection.
Author Contributions
Conceived and designed the experiments: CAMvdW CSP ESAdA BEEM
EGK. Performed the experiments: CAMvdW LSVB ACF CMR CCC
CLdLR. Analyzed the data: CAMvdW CSP HJvdH ACA BEEM EGK.
Contributed reagents/materials/analysis tools: KIC AMdM JEL EL
ECMvG ADMEO. Wrote the paper: CAMvdW CSP ESAdA HJvdH
ECMvG ADMEO BEEM EGK.
References
1. Romano CM, de Matos AM, Araujo ES, Villas-Boas LS, da Silva WC, et al.
(2010) Characterization of Dengue virus type 2: new insights on the 2010
Brazilian epidemic. PLoS One 5: e11811.
2. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, et al. (2002)
Differing influences of virus burden and immune activation on disease severity in
secondary dengue-3 virus infections. J Infect Dis 185: 1213–1221.
3. Martina BE, Koraka P, Osterhaus AD (2009) Dengue virus pathogenesis: an
integrated view. Clin Microbiol Rev 22: 564–581.
4. Halstead SB (2003) Neutralization and antibody-dependent enhancement of
dengue viruses. Adv Virus Res 60: 421–467.
5. Rothman AL (2011) Immunity to dengue virus: a tale of original antigenic sin
and tropical cytokine storms. Nat Rev Immunol 11: 532–543.
6. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, et al. (2006)
Microbial translocation is a cause of systemic immune activation in chronic HIV
infection. Nat Med 12: 1365–1371.
7. Hofer U, Speck RF (2009) Disturbance of the gut-associated lymphoid tissue is
associated with disease progression in chronic HIV infection. Semin Immuno-
pathol 31: 257–266.
8. van de Weg CA, Koraka P, van Gorp EC, Mairuhu AT, Supriatna M, et al.
(2012) Lipopolysaccharide levels are elevated in dengue virus infected patients
and correlate with disease severity. J Clin Virol 53: 38–42.
9. van de Weg CA, van Gorp EC, Supriatna M, Soemantri A, Osterhaus AD, et al.
(2012) Evaluation of the 2009 WHO dengue case classification in an Indonesian
pediatric cohort. Am J Trop Med Hyg 86: 166–170.
10. World Health Organization (2009) Dengue hemorrhagic fever: diagnosis,
treatment, prevention and control (new edition). Geneva.
11. de Souza VA, Fernandes S, Araujo ES, Tateno AF, Oliveira OM, et al. (2004)
Use of an immunoglobulin G avidity test to discriminate between primary and
secondary dengue virus infections. J Clin Microbiol 42: 1782–1784.
12. Felix AC, Romano CM, Centrone Cde C, Rodrigues CL, Villas-Boas L, et al.
(2012) Low sensitivity of NS1 protein tests evidenced during a dengue type 2
virus outbreak in Santos, Brazil, in 2010. Clin Vaccine Immunol 19: 1972–
1976.
13. Harris E, Roberts TG, Smith L, Selle J, Kramer LD, et al. (1998) Typing of
dengue viruses in clinical specimens and mosquitoes by single-tube multiplex
reverse transcriptase PCR. J Clin Microbiol 36: 2634–2639.
Immune Activation, LPS and Severe Dengue
PLOS Neglected Tropical Diseases | www.plosntds.org 12 May 2013 | Volume 7 | Issue 5 | e2236
14. van den Ham HJ, de Jager W, Bijlsma JW, Prakken BJ, de Boer RJ (2009)
Differential cytokine profiles in juvenile idiopathic arthritis subtypes revealed by
cluster analysis. Rheumatology (Oxford) 48: 899–905.
15. Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, et al. (1999)
Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-
binding protein in patients with severe sepsis and septic shock. J Infect Dis 180:
1584–1589.
16. Landmann R, Zimmerli W, Sansano S, Link S, Hahn A, et al. (1995) Increased
circulating soluble CD14 is associated with high mortality in gram-negative
septic shock. J Infect Dis 171: 639–644.
17. Bukh AR, Melchjorsen J, Offersen R, Jensen JM, Toft L, et al. (2011)
Endotoxemia is associated with altered innate and adaptive immune responses in
untreated HIV-1 infected individuals. PLoS One 6: e21275.
18. Redd AD, Dabitao D, Bream JH, Charvat B, Laeyendecker O, et al. (2009)
Microbial translocation, the innate cytokine response, and HIV-1 disease
progression in Africa. Proc Natl Acad Sci U S A 106: 6718–6723.
19. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, et al. (2012) Into the
eye of the cytokine storm. Microbiol Mol Biol Rev 76: 16–32.
20. Santos-Oliveira JR, Regis EG, Leal CR, Cunha RV, Bozza PT, et al. (2011)
Evidence that lipopolisaccharide may contribute to the cytokine storm and
cellular activation in patients with visceral leishmaniasis. PLoS Negl Trop Dis 5:
e1198.
21. Wang W, Deng M, Liu X, Ai W, Tang Q, et al. (2011) TLR4 activation induces
nontolerant inflammatory response in endothelial cells. Inflammation 34: 509–
518.
22. Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, et al. (2008) Human
mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce
growth factors by an NF kappa B- but not JNK-dependent mechanism.
Am J Physiol Cell Physiol 294: C675–682.
23. Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, et al. (2002)
Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes
by interferon-gamma: a molecular basis for priming and synergism with
bacterial lipopolysaccharide. Blood 99: 3427–3431.
24. Chen YC, Wang SY (2002) Activation of terminally differentiated human
monocytes/macrophages by dengue virus: productive infection, hierarchical
production of innate cytokines and chemokines, and the synergistic effect of
lipopolysaccharide. J Virol 76: 9877–9887.
25. Chen YC, Wang SY, King CC (1999) Bacterial lipopolysaccharide inhibits
dengue virus infection of primary human monocytes/macrophages by blockade
of virus entry via a CD14-dependent mechanism. J Virol 73: 2650–2657.
26. Tang Y, Kou Z, Zhang F, Yao X, Liu S, et al. (2010) Both viremia and cytokine
levels associate with the lack of severe disease in secondary dengue 1 infection
among adult Chinese patients. PLoS One 5: e15631.
27. Kurane I, Innis BL, Nimmannitya S, Nisalak A, Meager A, et al. (1991)
Activation of T lymphocytes in dengue virus infections. High levels of soluble
interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-
gamma in sera of children with dengue. J Clin Invest 88: 1473–1480.
28. Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, et al. (2004) IL-10 levels in
Dengue patients: some findings from the exceptional epidemiological conditions
in Cuba. J Med Virol 73: 230–234.
29. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al.
(1999) Elevated plasma interleukin-10 levels in acute dengue correlate with
disease severity. J Med Virol 59: 329–334.
30. Pacsa AS, Agarwal R, Elbishbishi EA, Chaturvedi UC, Nagar R, et al. (2000)
Role of interleukin-12 in patients with dengue hemorrhagic fever. FEMS
Immunol Med Microbiol 28: 151–155.
31. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, et al. (2008)
Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as
predictive factors for severity. BMC Infect Dis 8: 86.
32. Sierra B, Perez AB, Vogt K, Garcia G, Schmolke K, et al. (2010) MCP-1 and
MIP-1alpha expression in a model resembling early immune response to dengue.
Cytokine 52: 175–183.
33. Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, et al. (2006) MCP-1, a highly
expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome
patients, may cause permeability change, possibly through reduced tight
junctions of vascular endothelium cells. J Gen Virol 87: 3623–3630.
34. Azeredo EL, Zagne SM, Santiago MA, Gouvea AS, Santana AA, et al. (2001)
Characterisation of lymphocyte response and cytokine patterns in patients with
dengue fever. Immunobiology 204: 494–507.
35. Srikiatkhachorn A, Ajariyakhajorn C, Endy TP, Kalayanarooj S, Libraty DH,
et al. (2007) Virus-induced decline in soluble vascular endothelial growth
receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever.
J Virol 81: 1592–1600.
36. Chen JP, Lu HL, Lai SL, Campanella GS, Sung JM, et al. (2006) Dengue virus
induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein
10, which competitively inhibits viral binding to cell surface heparan sulfate.
J Immunol 177: 3185–3192.
37. Murphy KT, Walport PM (2008) Janeway’s immunobiology. New York:
Garland Science.
38. Saraiva M, O’Garra A (2010) The regulation of IL-10 production by immune
cells. Nat Rev Immunol 10: 170–181.
39. Hober D, Poli L, Roblin B, Gestas P, Chungue E, et al. (1993) Serum levels of
tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1
beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 48: 324–331.
40. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, et al. (2004) Dengue
hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis
189: 221–232.
41. Suharti C, van Gorp EC, Dolmans WM, Setiati TE, Hack CE, et al. (2003)
Cytokine patterns during dengue shock syndrome. Eur Cytokine Netw 14: 172–
177.
42. Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, et al. (1998)
Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever.
J Infect Dis 177: 778–782.
43. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, et al.
(1999) Early immune activation in acute dengue illness is related to development
of plasma leakage and disease severity. J Infect Dis 179: 755–762.
44. Caruso C, Candore G, Cigna D, Colucci AT, Modica MA (1993) Biological
significance of soluble IL-2 receptor. Mediators Inflamm 2: 3–21.
45. John CC, Opika-Opoka R, Byarugaba J, Idro R, Boivin MJ (2006) Low levels of
RANTES are associated with mortality in children with cerebral malaria. J Infect
Dis 194: 837–845.
Immune Activation, LPS and Severe Dengue
PLOS Neglected Tropical Diseases | www.plosntds.org 13 May 2013 | Volume 7 | Issue 5 | e2236
